Home › Trial NCT06771596
Nimotuzumab High-risk, Locally Advanced Squamous Cell Carcinoma of the Cervix
- Trial IDNCT06771596
- StatusActive Not Recruiting
- PhasePhase 2
- Study typeInterventional
- SponsorCancer Institute and Hospital, Chinese Academy of Medical Sciences
- Enrollment43
- Start date2021-05-12
- ConditionsUterine Cervical Neoplasms
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.